Akzo Nobel N.V. (AKZOY) will report earnings on April 22, 2026, after market close. The specialty chemicals company faces moderate expectations from Wall Street. Analysts forecast earnings per share of $0.30 and revenue of $2.74 billion. This earnings preview examines what to expect, historical performance patterns, and key metrics investors should monitor. The company’s recent track record shows mixed results, with some quarters beating estimates and others missing. Understanding these patterns helps investors prepare for potential surprises when AKZOY releases its latest financial results.
Analyst Expectations for AKZOY Earnings
Wall Street has set modest targets for Akzo Nobel’s upcoming earnings report. Analysts expect the company to deliver $0.30 in earnings per share and $2.74 billion in quarterly revenue. These estimates represent a cautious outlook for the specialty chemicals manufacturer.
EPS Forecast Analysis
The $0.30 EPS estimate marks a significant decline from recent quarters. In the previous quarter ending February 2026, the company missed expectations with $0.22 EPS versus a $0.29 estimate. Two quarters prior, AKZOY delivered $0.43 EPS against a $0.47 estimate. This downward trend in earnings suggests operational headwinds or margin compression in the coatings and specialty chemicals sector.
Revenue Estimate Breakdown
The $2.74 billion revenue forecast sits near the middle of recent quarterly performance. Last quarter brought $2.76 billion in actual revenue, exceeding the $2.33 billion estimate. Two quarters back, the company generated $2.63 billion against a $2.67 billion forecast. These numbers show revenue stability but with inconsistent estimate accuracy from analysts.
Historical Earnings Performance and Beat/Miss Pattern
Akzo Nobel’s recent earnings history reveals a mixed track record that investors should understand before the April 22 report. The company has alternated between beating and missing expectations, making prediction difficult.
Recent Quarter Results
In February 2026, AKZOY missed EPS expectations by delivering $0.22 versus the $0.29 estimate. However, revenue surprised positively at $2.76 billion compared to $2.33 billion forecast. Two quarters earlier in July 2025, the company missed EPS with $0.43 versus $0.47 expected but beat revenue with $2.63 billion against $2.67 billion estimate. The April 2025 quarter showed the opposite pattern: EPS beat at $0.33 versus $0.30 expected, and revenue exceeded at $2.86 billion versus $2.62 billion forecast.
Beat/Miss Probability Assessment
Based on this four-quarter history, AKZOY has missed EPS twice and beaten once, with one quarter pending results. Revenue shows similar inconsistency. The current $0.30 EPS estimate appears conservative given the company’s ability to occasionally surprise. However, the recent downward EPS trend suggests caution. Investors should expect a 50-50 probability of beating or missing the $0.30 EPS target.
Key Metrics and Financial Health
Understanding Akzo Nobel’s underlying financial metrics provides context for earnings expectations. The company operates in the specialty chemicals sector with exposure to decorative paints, performance coatings, and industrial applications.
Profitability and Margins
AKZOY maintains a trailing twelve-month net profit margin of 6.2 percent, indicating modest profitability in a competitive industry. The gross profit margin stands at 39.9 percent, showing reasonable pricing power on raw materials. Operating margin of 8.0 percent reflects the company’s ability to control costs. These metrics suggest the company operates efficiently but faces margin pressure typical of chemical manufacturers.
Balance Sheet and Liquidity
The company carries a debt-to-equity ratio of 1.04, indicating moderate leverage. Current ratio of 1.44 demonstrates adequate short-term liquidity to meet obligations. Free cash flow per share reached $1.14 trailing twelve months, supporting dividend payments of $0.64 per share. Interest coverage of 4.38 times shows the company can comfortably service debt obligations from operating earnings.
Valuation Metrics
AKZOY trades at a price-to-earnings ratio of 14.3 times, below the historical average for specialty chemicals companies. Price-to-sales ratio of 2.69 times appears reasonable given sector comparables. The company’s enterprise value-to-EBITDA multiple of 19.8 times suggests fair valuation in the current market environment.
What Investors Should Watch During AKZOY Earnings
The April 22 earnings call will provide crucial guidance on company direction. Investors should focus on specific metrics and management commentary that signal future performance.
Segment Performance and Pricing
Watch for details on decorative paints versus performance coatings revenue mix. Management commentary on pricing actions and raw material costs will indicate margin trajectory. The company’s ability to pass through inflation to customers directly impacts profitability. Any discussion of volume declines or market share losses deserves close attention.
Guidance and Forward Outlook
Management’s updated guidance for the remainder of 2026 matters more than the current quarter results. Look for commentary on demand trends in key markets like Europe and Asia. Any mention of restructuring costs, plant closures, or efficiency initiatives could signal margin improvement ahead. Dividend sustainability discussion will interest income-focused investors.
Cash Flow and Capital Allocation
Free cash flow generation remains critical for a company with 1.04 debt-to-equity ratio. Investors should monitor capital expenditure plans and working capital management. The company’s ability to fund dividends while reducing debt demonstrates financial discipline. Any changes to share buyback programs or acquisition plans warrant attention.
Final Thoughts
Akzo Nobel’s April 22 earnings report will reveal how the specialty chemicals company manages margin pressures and market volatility. With a $0.30 EPS estimate and $2.74 billion revenue target, the company shows stable fundamentals. Meyka AI rates AKZOY as B+, reflecting solid performance but moderate growth. Investors should prioritize management guidance, segment profitability, and cash flow over quarterly results. The 14.3 P/E multiple and 3.6 percent dividend yield provide reasonable value for patient investors.
FAQs
What EPS and revenue estimates should I expect for AKZOY earnings?
Analysts forecast $0.30 earnings per share and $2.74 billion in revenue for the April 22 report. These estimates represent a cautious outlook compared to recent quarters, with EPS declining from prior period results.
Has AKZOY beaten or missed earnings estimates recently?
The company shows mixed results. It missed EPS in February 2026 ($0.22 vs $0.29 estimate) but beat revenue. Two quarters prior, it missed EPS but beat revenue. This alternating pattern makes prediction difficult for the upcoming report.
What is Meyka AI’s rating for AKZOY and what does it mean?
Meyka AI rates AKZOY with a B+ grade, indicating neutral recommendation. This grade reflects S&P 500 comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are not guaranteed and we are not financial advisors.
What key metrics should I monitor during the earnings call?
Focus on segment revenue mix, pricing power commentary, raw material cost trends, and management guidance for 2026. Watch free cash flow generation, dividend sustainability, and any restructuring announcements that signal future profitability improvements.
Is AKZOY a good value at current price levels?
The company trades at 14.3 times earnings and 2.69 times sales, appearing reasonably valued for specialty chemicals. The 3.6 percent dividend yield offers income, but earnings volatility suggests moderate risk for conservative investors.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Earnings estimates are analyst projections and not guarantees of actual results. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)